Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
A multicenter, randomised, blind comparision of amrinone with milrinone after elective cardiac surgery.
Combined inotropic effects of amrinone
and epinephrine after cardiopulmonary bypass in humans.
A related phosphodiesterase inhibitor, amrinone (6) increased free flap blood flow in a small group of patients when administered intravenously and decreased vasospasm when applied topically.
It has been shown that amrinone, a related PDE-III inhibitor, experimentally improves perfusion in free flaps (9), presumably by a combination of vasodilation and improved cardiac output.
The inotropic effects of amrinone
and milrinone on neonatal and young canine cardiac muscle.